Last reviewed · How we verify

NCT05712395: NICE

The Effects of a Novel, Non-ischemic and Pain-free Exercise Intervention in Peripheral Artery Disease

Recruiting now NA Last updated 12 June 2025
What this trial tests

NA trial testing Exercise in Claudication in 100 participants. Currently enrolling.

Timeline
9 September 2024
Primary endpoint
31 July 2029
31 July 2029

Quick facts

Lead sponsorUniversity of Oklahoma
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment100
Start date9 September 2024
Primary completion31 July 2029
Estimated completion31 July 2029
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Oklahoma

Who can join

60 and older, any sex, with Claudication or Peripheral Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a 3-month, prospective, randomized controlled clinical trial designed to address the efficacy of the Non-Ischemic Exercise (NICE) program to improve exercise and vascular outcome measures in patients with peripheral artery disease (PAD).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Claudication

Currently open trials in the same condition.

Other University of Oklahoma trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05712395.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing